Monte Rosa Therapeutics, Inc. (GLUE) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$123.7M

Net Income/Loss (FY2025)

-$38.6M

Total Assets (FY2025)

$448.7M

Total Equity (FY2025)

$233.1M

Cash Flows from Operating Activities (FY2025)

-$22.8M

Source: Monte Rosa Therapeutics, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.